Login
$LASE
$0.74 -$0.00 (0.32%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current Assets
Cash and Cash Equivalents
Cash
Accounts receivable, net of allowance for expected credit losses of $2,240 and $0, respectively
Non-Affiliate
Affiliate
Total accounts receivable, net of allowance for expected credit losses of $2,240 and $0, respectively
Inventory
Contract assets
Affiliate
Total contract assets
Inventories, net of reserves of $562,170 and $503,835, respectively
Other Assets
Other Current Assets
Deferred financing costs
Prepaid and other current assets
Total Current Assets
Property, plant, and equipment, net
Total intangible assets
Intangible assets, net
Operating lease right-of-use asset
Other long-term assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable
Non-Affiliate
Affiliate
Nonrelated Party
Related Party
Total accounts payable
Short term loan
Nonrelated Party
Related Party
Accrued expenses
Deferred revenue
Contract liabilities
Principal amount
Nonrelated Party
Related Party
Lease liability, current
Derivative liability
Total Current Liabilities
Lease liability – non-current
Total Long Term Liabilities
Total Liabilities
Commitments and Contingencies
Stockholders’ Deficit
Preferred shares par value $0.001: 10,000,000 shares authorized, no shares were issued and outstanding at June 30, 2026, and December 31, 2025, respectively
Common shares par Value $0.001: 100,000,000 shares authorized; 47,641,766 and 22,852,753 issued, and 47,634,388 and 22,845,345 outstanding, at June 30, 2026, and December 31, 2025, respectively
Additional paid-in capital
Shares to be issued
Nonrelated Party
Total shares to be issued
Accumulated deficit
Treasury Stock
Total Stockholders Equity
Treasury shares (7,378 and 7,378 shares, respectively)
Total Stockholders’ Deficit
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support